ADAR1 Capital Management »

Corbus Pharmaceuticals Hldgs shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $628k 16k 39.24

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
Octagon Capital Advisors
OrbiMed Advisors
BlackRock
BlackRock
Ikarian Capital
Tang Capital Management
Vanguard Group
State Street Corporation
T. Rowe Price Associates
Susquehanna International
Morgan Stanley
Geode Capital Management
Sio Capital Management
Schonfeld Strategic Advisors

View all funds holding Corbus Pharmaceuticals Hldgs